candesartan has been researched along with DDD MPGNII in 4 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan treatment ameliorated the glomerular morphological findings at six weeks after disease induction." | 1.31 | Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. ( Gejyo, F; Ikezumi, Y; Ito, Y; Kawachi, H; Koike, H; Morioka, Y; Nakamura, T; Nakatsue, T; Natori, Y; Oyanagi, A; Shimizu, F, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamei, K | 1 |
| Nakagawa, A | 1 |
| Otsuka, Y | 1 |
| Nakayama, M | 1 |
| Kobayashi, S | 1 |
| Matsuoka, K | 1 |
| Iijima, K | 1 |
| Moriyama, T | 1 |
| Fujibayashi, M | 1 |
| Fujiwara, Y | 1 |
| Kaneko, T | 1 |
| Xia, C | 1 |
| Imai, E | 1 |
| Kamada, T | 1 |
| Ando, A | 1 |
| Ueda, N | 1 |
| Nakamura, T | 2 |
| Obata, J | 1 |
| Kimura, H | 1 |
| Ohno, S | 1 |
| Yoshida, Y | 1 |
| Kawachi, H | 2 |
| Shimizu, F | 2 |
| Ito, Y | 1 |
| Morioka, Y | 1 |
| Nakatsue, T | 1 |
| Koike, H | 1 |
| Ikezumi, Y | 1 |
| Oyanagi, A | 1 |
| Natori, Y | 2 |
| Gejyo, F | 1 |
4 other studies available for candesartan and DDD MPGNII
| Article | Year |
|---|---|
Chronic glomerulonephritis associated with IgG subclass deficiency.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Benzimidazoles | 2007 |
Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cell | 1995 |
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; | 1999 |
Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis.
Topics: Animals; Antibodies, Monoclonal; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Chemok | 2002 |